Skip to main content
Top
Published in: Journal of Cancer Education 3/2016

01-09-2016

Tweeting About Prostate and Testicular Cancers: What Are Individuals Saying in Their Discussions About the 2013 Movember Canada Campaign?

Authors: Caroline A. Bravo, Laurie Hoffman-Goetz

Published in: Journal of Cancer Education | Issue 3/2016

Login to get access

Abstract

Effective and persuasive health campaigns are an important tool for promoting cancer prevention education. The 2013 Movember Canada campaign presented an opportunity to raise awareness and funds about men’s health with a particular focus on prostate and testicular cancers. The Movember campaign encouraged participants to talk about men’s health (including prostate and testicular cancers) and had a strong presence on social media sites such as Twitter in November 2013. The objective of this study was to analyze tweets about the 2013 Movember Canada for underlying themes in order understand what those discussions were about. A directed content analysis methodology was used to analyze 2400 tweets. Tweets were read and coded for overt and latent themes in an iterative fashion until saturation of themes occurred. The major themes identified in the tweets were fundraising as a priority (34 %), making a change to men’s health (18 %), the campaign as a moustache contest rather than a charity (26 %), the use of masculine metaphors/imagery (9 %), and the role of women as moustache supporters (4 %). Findings from Twitter suggest that users rarely associate their campaign efforts with prostate and/or testicular cancer in public online conversations about the 2013 Movember Canada campaign.
Literature
4.
go back to reference Charvat H, Bossard N, Daubisse L, Binder F, Belot A, Remontet L (2013) Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers. Cancer Epidemiol 37(6):857–863. doi:10.1016/j.canep.2013.08.006 CrossRefPubMed Charvat H, Bossard N, Daubisse L, Binder F, Belot A, Remontet L (2013) Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers. Cancer Epidemiol 37(6):857–863. doi:10.​1016/​j.​canep.​2013.​08.​006 CrossRefPubMed
7.
go back to reference Shabbir M, Morgan RJ (2004) Testicular cancer. J R Soc Health 124(5):217–218CrossRef Shabbir M, Morgan RJ (2004) Testicular cancer. J R Soc Health 124(5):217–218CrossRef
9.
go back to reference Robert J (2013) Individualistic philanthropy: the paradox of embodied participation for health-related fund-raising campaigns. Int J Nonprofit Volunt Sect Mark 18(4):261–274. doi:10.1002/nvsm.1471 CrossRef Robert J (2013) Individualistic philanthropy: the paradox of embodied participation for health-related fund-raising campaigns. Int J Nonprofit Volunt Sect Mark 18(4):261–274. doi:10.​1002/​nvsm.​1471 CrossRef
12.
13.
go back to reference Bravo CA, Hoffman-Goetz L (2015) Tweeting about prostate and testicular cancers: do twitter conversations and the 2013 Movember Canada campaign objectives align? J Cancer Educ. doi:10.1007/s13187-015-0796-1 PubMed Bravo CA, Hoffman-Goetz L (2015) Tweeting about prostate and testicular cancers: do twitter conversations and the 2013 Movember Canada campaign objectives align? J Cancer Educ. doi:10.​1007/​s13187-015-0796-1 PubMed
Metadata
Title
Tweeting About Prostate and Testicular Cancers: What Are Individuals Saying in Their Discussions About the 2013 Movember Canada Campaign?
Authors
Caroline A. Bravo
Laurie Hoffman-Goetz
Publication date
01-09-2016
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 3/2016
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0838-8

Other articles of this Issue 3/2016

Journal of Cancer Education 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine